image
Inhibikase Therapeutics, Inc. IKT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.88
-3.16 %
$ 140 M
Market Cap
-3.17
P/E
Price Target Average
245.74%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
--61.96%
Net Income Estimate
30.06%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Inhibikase Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for IKT of $6.5 , with forecasts ranging from a low of $5 to a high of $8 .
IKT Lowest Price Target Wall Street Target
5 USD 165.96%
IKT Average Price Target Wall Street Target
6.5 USD 245.74%
IKT Highest Price Target Wall Street Target
8 USD 325.53%
Price
Max Price Target
Min Price Target
Average Price Target
8877665544332211Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart IKT

image
$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart IKT

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)($180.0m)($180.0m)($200.0m)($200.0m)202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart IKT

image
$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)202120212022202220232023202420242025202520262026202720272028202820292029